This inventor holds 1 USPTO granted patent and 6 published patent applications and 1 EPO patent. Top assignee: Oncodesign Precision Medicine. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Audrey Dumoulin - Innovator in Precision Medicine
Introduction: Audrey Dumoulin is a talented inventor based in Antony, France. She is currently associated with Oncodesign Precision Medicine, where she contributes to advancements in the field of medical research. Despite having no granted patents to her name, her work in developing innovative solutions is noteworthy.
Latest Patents: Audrey's latest patent applications include "Macrocyclic LRRK2 Kinase Inhibitors," which focuses on compounds of formula (I) that are useful as LRRK2 kinase inhibitors. Another application is titled "New Macrocyclic LRRK2 Kinase Inhibitors," which also involves compounds of Formula (I). These applications reflect her commitment to addressing significant challenges in precision medicine.
Conclusion: Audrey Dumoulin is an emerging figure in the field of precision medicine, with a focus on innovative solutions for medical challenges. Her contributions, although not yet reflected in granted patents, demonstrate her potential impact on the industry.